{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:55:28Z","timestamp":1788447328881,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12185-019-02814-8","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T07:02:47Z","timestamp":1578985367000},"page":"535-543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Molecular and clinical profile of type 2 von Willebrand disease in Iran: a thirteen-year experience"],"prefix":"10.1007","volume":"111","author":[{"given":"Maryam","family":"Rassoulzadegan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereydoun","family":"Ala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Jazebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Said","family":"Enayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Tabibian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Bahraini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0125-9319","authenticated-orcid":false,"given":"Akbar","family":"Dorgalaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"issue":"1","key":"2814_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.21037\/aob.2018.01.01","volume":"3","author":"A Dorgalaleh","year":"2018","unstructured":"Dorgalaleh A, Tabibian S, Shams M, Ala F, Bahoush G, Jazebi M, et al. Von Willebrand disease in Iran: diagnosis and management. Ann Blood. 2018;3(1):4.","journal-title":"Ann Blood"},{"issue":"1","key":"2814_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","volume":"8","author":"M Bowman","year":"2010","unstructured":"Bowman M, Hopman WM, Rapson D, Lillicrap D, James P. The prevalence of symptomatic von Willebrand disease in primary care practice. J Thromb Haemost. 2010;8(1):213\u20136.","journal-title":"J Thromb Haemost"},{"key":"2814_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-3-319-76723-9","volume-title":"von Willebrand disease. Congenital bleeding disorders","author":"A Dorgalaleh","year":"2018","unstructured":"Dorgalaleh A, Tabibian S, Shiravand Y, Favaloro EJ. von Willebrand disease. Congenital bleeding disorders. Berlin: Springer; 2018. p. 57\u2013102."},{"issue":"4","key":"2814_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/jcm6040045","volume":"6","author":"G Castaman","year":"2017","unstructured":"Castaman G, Linari S. Diagnosis and treatment of von Willebrand disease and rare bleeding disorders. J Clin Med. 2017;6(4):45.","journal-title":"J Clin Med"},{"key":"2814_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/jth.12257","volume":"11","author":"D Lillicrap","year":"2013","unstructured":"Lillicrap D. Translational medicine advances in von Willebrand disease. J Thromb Haemost. 2013;11:75\u201383.","journal-title":"J Thromb Haemost"},{"issue":"08","key":"2814_CR6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1055\/s-0037-1613992","volume":"84","author":"J Sadler","year":"2000","unstructured":"Sadler J, Mannucci P, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost. 2000;84(08):160\u201374.","journal-title":"Thromb Haemost"},{"issue":"1","key":"2814_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","volume":"109","author":"A Goodeve","year":"2007","unstructured":"Goodeve A, Eikenboom J, Castaman G, Rodeghiero F, Federici AB, Batlle J, et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood. 2007;109(1):112\u201321.","journal-title":"Blood"},{"key":"2814_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/jth.12226","volume":"11","author":"C Casari","year":"2013","unstructured":"Casari C, Lenting P, Wohner N, Christophe O, Denis C. Clearance of von Willebrand factor. J Thromb Haemost. 2013;11:202\u201311.","journal-title":"J Thromb Haemost"},{"issue":"01","key":"2814_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1160\/TH12-07-0475","volume":"109","author":"F Ahmad","year":"2013","unstructured":"Ahmad F, Jan R, Kannan M, Obser T, Hassan MI, Oyen F, et al. Characterisation of mutations and molecular studies of type 2 von Willebrand disease. Thromb Haemost. 2013;109(01):39\u201346.","journal-title":"Thromb Haemost"},{"issue":"6","key":"2814_CR10","doi-asserted-by":"publisher","first-page":"e502","DOI":"10.1111\/hae.13084","volume":"22","author":"M Pagliari","year":"2016","unstructured":"Pagliari M, Baronciani L, Stufano F, Garcia-Oya I, Cozzi G, Franchi F, et al. von Willebrand disease type 1 mutation p.Arg1379Cys and the variant p.Ala1377Val synergistically determine a 2M phenotype in four Italian patients. Haemophilia. 2016;22(6):e502\u201311.","journal-title":"Haemophilia"},{"issue":"4","key":"2814_CR11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1365-2141.1991.tb08089.x","volume":"79","author":"D Lillicrap","year":"1991","unstructured":"Lillicrap D, Murray EW, Benford K, Blanchette VS, Rivard GE, Wensley R, et al. Recurring mutations at CpG dinucleotides in the region of the von Willebrand factor gene encoding the glycoprotein Ib binding domain, in patients with type IIB von Willebrand\u2019s disease. Br J Haematol. 1991;79(4):612\u20137.","journal-title":"Br J Haematol"},{"issue":"5","key":"2814_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/MBC.0000000000000620","volume":"28","author":"L Skeith","year":"2017","unstructured":"Skeith L, Rydz N, O\u2019Beirne M, Goodyear D, Li H, Poon M-C. Pregnancy loss in women with von Willebrand disease: a single-center pilot study. Blood Coagul Fibrinolysis. 2017;28(5):393\u20137.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"2814_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1471-0528.1998.tb10093.x","volume":"105","author":"RA Kadir","year":"1998","unstructured":"Kadir RA, Lee CA, Sabin CA, Pollard D, Economides DL. Pregnancy in women with von Willebrand\u2019s disease or factor XI deficiency. BJOG. 1998;105(3):314\u201321.","journal-title":"BJOG"},{"issue":"2","key":"2814_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1538-7836.2005.01150.x","volume":"3","author":"JL Kujovich","year":"2005","unstructured":"Kujovich JL. von Willebrand disease and pregnancy. J Thromb Haemost. 2005;3(2):246\u201353.","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2814_CR15","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1055\/s-0036-1587686","volume":"42","author":"E Reynen","year":"2016","unstructured":"Reynen E, James P. Von Willebrand disease and pregnancy: a review of evidence and expert opinion. Semin Thromb Hemost. 2016;42(7):717\u201323.","journal-title":"Semin Thromb Hemost"},{"key":"2814_CR16","first-page":"3","volume":"1","author":"D Lillicrap","year":"2005","unstructured":"Lillicrap D. The molecular genetics of von Willebrand disease. Haematol Rep. 2005;1:3\u20138.","journal-title":"Haematol Rep"},{"issue":"3","key":"2814_CR17","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1172\/JCI112394","volume":"77","author":"TS Zimmerman","year":"1986","unstructured":"Zimmerman TS, Dent JA, Ruggeri ZM, Nannini LH. Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE). J Clin Invest. 1986;77(3):947\u201351.","journal-title":"J Clin Invest"},{"issue":"1","key":"2814_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12959-016-0092-2","volume":"14","author":"M-C Shen","year":"2016","unstructured":"Shen M-C, Chen M, Ma G-C, Chang S-P, Lin C-Y, Lin B-D, et al. De novo mutation and somatic mosaicism of gene mutation in type 2A, 2B and 2M VWD. Thromb J. 2016;14(1):36.","journal-title":"Thromb J"},{"issue":"6","key":"2814_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s002770100303","volume":"80","author":"E Rendal","year":"2001","unstructured":"Rendal E, Penas N, Larrabeiti B, P\u00e9rez A, Vale A, L\u00f3pez-Fern\u00e1ndez M, et al. Type 2B von Willebrand\u2019s disease due to Val1316Met mutation. Heterogeneity in the same sibship. Ann Hematol. 2001;80(6):354\u201360.","journal-title":"Ann Hematol"},{"issue":"14","key":"2814_CR20","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1182\/blood-2008-06-165233","volume":"113","author":"SC Jackson","year":"2009","unstructured":"Jackson SC, Sinclair GD, Cloutier S, Duan Z, Rand ML, Poon MC. The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation. Blood. 2009;113(14):3348\u201351.","journal-title":"Blood"},{"issue":"4","key":"2814_CR21","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1172\/JCI115122","volume":"87","author":"AM Randi","year":"1991","unstructured":"Randi AM, Rabinowitz I, Mancuso DJ, Mannucci PM, Sadler JE. Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences. J Clin Invest. 1991;87(4):1220\u20136.","journal-title":"J Clin Invest"},{"issue":"8","key":"2814_CR22","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1182\/blood.V79.8.2048.2048","volume":"79","author":"PA Kroner","year":"1992","unstructured":"Kroner PA, Kluessendorf M, Scott J, Montgomery RR. Expressed full-length von Willebrand factor containing missense mutations linked to type IIB von Willebrand disease shows enhanced binding to platelets. Blood. 1992;79(8):2048\u201355.","journal-title":"Blood"},{"issue":"4","key":"2814_CR23","first-page":"414","volume":"86","author":"P Casa\u00f1a","year":"2001","unstructured":"Casa\u00f1a P, Mart\u00ednez F, Haya S, Tavares A, Aznar JA. New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand\u2019s disease. Haematologica. 2001;86(4):414\u20139.","journal-title":"Haematologica"},{"issue":"03","key":"2814_CR24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1160\/TH08-08-0500","volume":"101","author":"I Corrales","year":"2009","unstructured":"Corrales I, Ram\u00edrez L, Altisent C, Parra R, Vidal F. Rapid molecular diagnosis of von Willebrand disease by direct sequencing. Detection of 12 novel putative mutations in VWF gene. Thromb Haemost. 2009;101(03):570\u20136.","journal-title":"Thromb Haemost"},{"issue":"4","key":"2814_CR25","first-page":"135","volume":"32","author":"E Shahverdi","year":"2016","unstructured":"Shahverdi E, Moghaddam M, Talebian A, Abolghasemi H. Distribution of blood groups in the Iranian general population. J Blood Group Serol Mol Genet. 2016;32(4):135.","journal-title":"J Blood Group Serol Mol Genet"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02814-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-019-02814-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02814-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T23:03:07Z","timestamp":1610578987000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-019-02814-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["2814"],"URL":"https:\/\/doi.org\/10.1007\/s12185-019-02814-8","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,14]]},"assertion":[{"value":"17 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}